The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
2021 · npj Breast Cancer · 257 citations
https://doi.org/10.1038/s41523-021-00346-1
L
Leonie Voorwerk
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
3.5K
Citations
18
h-index
22
i10-index
Leonie Voorwerk is an academic researcher from The Netherlands Cancer Institute. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer Genomics and Diagnostics & Cancer Cells and Metastasis. The author has an h-index of 18, co-authored 34 publications.
ORCID: 0000-0001-5338-7358Papers by this author
worksSpatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer
2021 · Nature Communications · 234 citations
https://doi.org/10.1038/s41467-021-25962-0
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
2020 · npj Breast Cancer · 198 citations
https://doi.org/10.1038/s41523-020-0156-0
IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer
2022 · Cancer Cell · 192 citations
https://doi.org/10.1016/j.ccell.2022.11.014
LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer
2022 · Nature Cancer · 61 citations
https://doi.org/10.1038/s43018-022-00339-4
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial
2023 · Nature Cancer · 36 citations
https://doi.org/10.1038/s43018-023-00542-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat